Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Abstract CT079: The Pseudovax trial: A novel peptide vaccine targeting mutated GNAS for pseudomyxoma peritonei

Kjersti Flatmark, Annette Torgunrud, Fleten G. Karianne, Ben Davidson, Hedvig V. Juel, Nadia Mensali, Christin Lund Andersen, Else Marit Inderberg

Cancer Res (2024) 84 (7_Supplement): CT079.

https://doi.org/10.1158/1538-7445.AM2024-CT079

Published: 05 April 2024

View article titled, Abstract CT079: The Pseudovax trial: A novel peptide vaccine targeting mutated GNAS for pseudomyxoma peritonei

Journal Articles

Abstract 5052: Novel drug resistance mechanisms and drug targets in BRAF mutated peritoneal metastasis from colorectal cancer

Christin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, Vegar J. Dagenborg, Ida S. Frøysnes, Mette M. Larsen, Ben Davidson, Stein Larsen, Kjersti Flatmark

Cancer Res (2024) 84 (6_Supplement): 5052.

https://doi.org/10.1158/1538-7445.AM2024-5052

Published: 22 March 2024

View article titled, Abstract 5052: Novel drug resistance mechanisms and drug targets in <em>BRAF</em> mutated peritoneal metastasis from colorectal cancer

Journal Articles

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers

Cancer Res (2020) 80 (20): 4514–4526.

https://doi.org/10.1158/0008-5472.CAN-19-3971

Published: 15 October 2020

View article titled, Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers

Includes: Supplementary data

Journal Articles

Abstract 5182: Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma

Hadil Onallah, Claes G Trope, Thea E. Hetland Falkenthal, Ben Davidson, Reuven Reich

Cancer Res (2018) 78 (13_Supplement): 5182.

https://doi.org/10.1158/1538-7445.AM2018-5182

Published: 01 July 2018

View article titled, Abstract 5182: Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma

Journal Articles

Abstract 517: LncRNA expression at the different site of high-grades serous carcinoma

Natalie Filippov-Levy, Yoav Smith, Claes Gøran Trope, Ben Davidson, Reuven Reich

Cancer Res (2018) 78 (13_Supplement): 517.

https://doi.org/10.1158/1538-7445.AM2018-517

Published: 01 July 2018

View article titled, Abstract 517: LncRNA expression at the different site of high-grades serous carcinoma

Journal Articles

Abstract 2031: The noncanonical pathways of transforming growth factor β in ovarian carcinoma

Liora Jacobs Catane, Claes G. Trope, Ben Davidson, Reuven Reich

Cancer Res (2018) 78 (13_Supplement): 2031.

https://doi.org/10.1158/1538-7445.AM2018-2031

Published: 01 July 2018

View article titled, Abstract 2031: The noncanonical pathways of transforming growth factor β in ovarian carcinoma

Journal Articles

Abstract CT094: Novel treatment with intraperitoneal MOC31PE immunotoxin in colorectal peritoneal metastasis: Long-term outcome from the ImmunoPeCa phase I/II trial

Ida S. Froysnes, Yvonne Andersson, Stein Larsen, Ben Davidson, Janne-Merete T. Oien, Kari H. Olsen, Karl-Erik Giercksky, Lars Julsrud, Oystein Fodstad, Svein Dueland, Kjersti Flatmark

Cancer Res (2018) 78 (13_Supplement): CT094.

https://doi.org/10.1158/1538-7445.AM2018-CT094

Published: 01 July 2018

View article titled, Abstract CT094: Novel treatment with intraperitoneal MOC31PE immunotoxin in colorectal peritoneal metastasis: Long-term outcome from the ImmunoPeCa phase I/II trial

Journal Articles

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1

Jin-Gyoung Jung, Ie-Ming Shih, Joon Tae Park, Emily Gerry, Tae Hoen Kim, Ayse Ayhan, Karen Handschuh, Ben Davidson, Amanda N. Fader, Licia Selleri, Tian-Li Wang

Cancer Res (2016) 76 (21): 6351–6361.

https://doi.org/10.1158/0008-5472.CAN-16-0980

Published: 31 October 2016

View article titled, Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1

Includes: Supplementary data

Journal Articles

Abstract CT055: Novel intraperitoneal treatment for peritoneal metastases: results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I clinical trial

Kjersti Flatmark, Yvonne Andersson, Ben Davidson, Svein Dueland, Øystein Fodstad, Ida S. Frøysnes, Karl Erik Giercksky, Lars Julsrud, Stein G. Larsen, Kari H. Olsen, Janne M T Øien.

Cancer Res (2016) 76 (14_Supplement): CT055.

https://doi.org/10.1158/1538-7445.AM2016-CT055

Published: 15 July 2016

View article titled, Abstract CT055: Novel intraperitoneal treatment for peritoneal metastases: results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I clinical trial

Journal Articles

Abstract 5170: The autotaxin-lysophosphatidic acid signaling pathways in ovarian carcinoma

Hadil Onalla, Claes Tropé, Reuven Reich, Ben Davidson

Cancer Res (2015) 75 (15_Supplement): 5170.

https://doi.org/10.1158/1538-7445.AM2015-5170

Published: 01 August 2015

View article titled, Abstract 5170: The autotaxin-lysophosphatidic acid signaling pathways in ovarian carcinoma

Journal Articles

Abstract 5166: THE WNT SIGNALING PATHWAY IN THE OVARIAN CARCINOMA

michal chehover, Claes Tropé, Reuven Reich, Ben Davidson

Cancer Res (2015) 75 (15_Supplement): 5166.

https://doi.org/10.1158/1538-7445.AM2015-5166

Published: 01 August 2015

View article titled, Abstract 5166: THE WNT SIGNALING PATHWAY IN THE OVARIAN CARCINOMA

Journal Articles

Abstract 3197: Exosome secretion in ovarian carcinoma

Esther C. Broner, Tali Tavor Re'em, Claes Tropé, Ben Davidson, Reuven Reich

Cancer Res (2015) 75 (15_Supplement): 3197.

https://doi.org/10.1158/1538-7445.AM2015-3197

Published: 01 August 2015

View article titled, Abstract 3197: Exosome secretion in ovarian carcinoma

Journal Articles

Abstract 401: Gene expression signatures differentiate primary and metastatic uterine leiomyosarcoma.

Ben Davidson, Vera Maria Abeler, Mette Førsund, Arild Holth, Ie-Ming Shih, Gunnar B. Kristensen, Li Chen, Yanqin Yang, Tian-Li Wang

Cancer Res (2013) 73 (8_Supplement): 401.

https://doi.org/10.1158/1538-7445.AM2013-401

Published: 15 April 2013

View article titled, Abstract 401: Gene expression signatures differentiate primary and metastatic uterine leiomyosarcoma.

Journal Articles

Abstract 3052: Ovarian carcinoma derived exosomes: miRNA signatures and role in cancer progression .

Olga Vaksman (Goreshnik), Ben Davidson, Claes G. Trope', Reuven Reich

Cancer Res (2013) 73 (8_Supplement): 3052.

https://doi.org/10.1158/1538-7445.AM2013-3052

Published: 15 April 2013

View article titled, Abstract 3052: Ovarian carcinoma derived exosomes: miRNA signatures and role in cancer progression .

Journal Articles

Abstract LB-189: BIRC5 (Survivin) is a prognostic biomarker and potential drug target for patients with malignant peripheral nerve sheath tumors.

Matthias Kolberg, Maren Høland, Trude H. Ågesen, Rolf I. Skotheim, Bodil Bjerkehagen, Kirsten S. Hall, Fredrik Mertens, Sigbjørn Smeland, Dina C. Lev, Ben Davidson, Ragnhild A. Lote

Cancer Res (2013) 73 (8_Supplement): LB-189.

https://doi.org/10.1158/1538-7445.AM2013-LB-189

Published: 15 April 2013

View article titled, Abstract LB-189: BIRC5 (Survivin) is a prognostic biomarker and potential drug target for patients with malignant peripheral nerve sheath tumors.

Journal Articles

IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer

Sarah Hsu, Marianne Kim, Lidia Hernandez, Valentina Grajales, Anne Noonan, Miriam Anver, Ben Davidson, Christina M. Annunziata

Cancer Res (2012) 72 (21): 5494–5504.

https://doi.org/10.1158/0008-5472.CAN-11-3993

Published: 31 October 2012

View article titled, IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer

Includes: Supplementary data

Journal Articles

Abstract 815: The role of spleen tyrosine kinase (SYK) in paclitaxel resistant ovarian cancer

Stephanie Gaillard, Alexander Stoeck, Ben Davidson, Tian-Li Wang, Ie-Ming Shih

Cancer Res (2012) 72 (8_Supplement): 815.

https://doi.org/10.1158/1538-7445.AM2012-815

Published: 15 April 2012

View article titled, Abstract 815: The role of spleen tyrosine kinase (SYK) in paclitaxel resistant ovarian cancer

Journal Articles

Abstract 1479: IKK-epsilon contributes to the malignant progression of ovarian cancer

Christina M. Annunziata, Sarah Hsu, Lidia Hernandez, Elise Kohn, Ben Davidson

Cancer Res (2011) 71 (8_Supplement): 1479.

https://doi.org/10.1158/1538-7445.AM2011-1479

Published: 15 April 2011

View article titled, Abstract 1479: IKK-epsilon contributes to the malignant progression of ovarian cancer

Journal Articles

Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian Cancer

Lídia Hernandez, Sarah C. Hsu, Ben Davidson, Michael J. Birrer, Elise C. Kohn, Christina M. Annunziata

Cancer Res (2010) 70 (10): 4005–4014.

https://doi.org/10.1158/0008-5472.CAN-09-3912

Published: 12 May 2010

View article titled, Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian Cancer

Includes: Supplementary data

Journal Articles

Abstract 3147: Alternative splicing of Lysyl Oxidase-like 4 in ovarian carcinoma

Shulamit Sebban, Regina Golan-Gerstl, Rotem Karni, Ben Davidson, Reuven Reich

Cancer Res (2010) 70 (8_Supplement): 3147.

https://doi.org/10.1158/1538-7445.AM10-3147

Published: 15 April 2010

View article titled, Abstract 3147: Alternative splicing of Lysyl Oxidase-like 4 in ovarian carcinoma

NARROW

Abstract CT079: The Pseudovax trial: A novel peptide vaccine targeting mutated GNAS for pseudomyxoma peritonei

Abstract 5052: Novel drug resistance mechanisms and drug targets in BRAF mutated peritoneal metastasis from colorectal cancer

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers

Abstract 5182: Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma

Abstract 517: LncRNA expression at the different site of high-grades serous carcinoma

Abstract 2031: The noncanonical pathways of transforming growth factor β in ovarian carcinoma

Abstract CT094: Novel treatment with intraperitoneal MOC31PE immunotoxin in colorectal peritoneal metastasis: Long-term outcome from the ImmunoPeCa phase I/II trial

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1

Abstract CT055: Novel intraperitoneal treatment for peritoneal metastases: results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I clinical trial

Abstract 5170: The autotaxin-lysophosphatidic acid signaling pathways in ovarian carcinoma

Abstract 5166: THE WNT SIGNALING PATHWAY IN THE OVARIAN CARCINOMA

Abstract 3197: Exosome secretion in ovarian carcinoma

Abstract 401: Gene expression signatures differentiate primary and metastatic uterine leiomyosarcoma.

Abstract 3052: Ovarian carcinoma derived exosomes: miRNA signatures and role in cancer progression .

Abstract LB-189: BIRC5 (Survivin) is a prognostic biomarker and potential drug target for patients with malignant peripheral nerve sheath tumors.

IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer

Abstract 815: The role of spleen tyrosine kinase (SYK) in paclitaxel resistant ovarian cancer

Abstract 1479: IKK-epsilon contributes to the malignant progression of ovarian cancer

Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian Cancer

Abstract 3147: Alternative splicing of Lysyl Oxidase-like 4 in ovarian carcinoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only